U.S. Immigration Data

Priority dates, work visas, and labor market data

Sr. Validation Specialist, Pharmaceuticals

H-1B & Green Card Salary Data and Market Analysis

Only 2 filings match this exact title. For the full picture, see the broader Specialist profile (123 filings).
View Specialist →

2

Total Filings

All time (charts below use selected years)

$108,202

Median Salary

Across filings in selected period

1

Top Employers

Hiring This Role
Salary Distribution (All Employers + Top Employer Overlays)
10th Percentile

$108,202

25th Percentile

$108,202

Median (50th)

$108,202

75th Percentile

$108,202

90th Percentile

$108,202

See all H-1B/PERM filings for this role →

Chart data not available

Top Employers Hiring Sr. Validation Specialist, Pharmaceuticals
Employer Filings Median Salary Salary Range Approval Rate
GLENMARK PHARMACEUTICALS INC., USA 2 $108,202 $108,202 - $108,202 50.0%
Salary Distribution by Experience Level
Experience Level Filings Median Salary Salary Range
Senior 2 $108,202 $108,202 - $108,202

Chart data not available

Related Roles & Career Progression

These roles are variations of Sr. Validation Specialist, Pharmaceuticals with different seniority levels.

Role Experience Level Filings Avg Salary
Sr. Validation Specialist, Pharmaceuticals 2 $108,202
Filing Volume Trend
Loading chart...
Loading chart...
Median Salary Trend
Loading chart...
Loading chart...
Year-over-Year Statistics
Fiscal Year Filings Median Salary Approval Rate
2025 1 $108,202 0.0%
2026 1 $108,202 100.0%
Company Comparison - Sr. Validation Specialist, Pharmaceuticals

Compare how top companies pay for this role.

Company Filings Median Salary Approval Rate
GLENMARK PHARMACEUTICALS INC., USA 2 $108,202 50.0%
Data Source: U.S. Department of Labor (DOL) H-1B and green card (PERM) disclosure data. Data shown for fiscal years 2021 to present. Last updated: August 31, 2026

Note on Salary Data: For data quality, we exclude salaries below $30,000 (likely data entry errors) and above $1,000,000 (lacking automated validation for ultra-high compensation packages). This may affect statistics for some executive and specialized positions.